Synthetic circuits rely on predictable signal processing at the interface of biological input sensors and output actuators. However, constraints in matching signal input/output (I/O) currently limit the possible functions that can be designed.^[@ref1]^ Accordingly, the integration of subtle inputs with general stabilizing and modulating networks is needed to successfully actuate complex biological programs. Such approaches may further help provide context insulation and stability toward signal errors inherent in many human-designed biological systems, including multicomponent synthetic computation networks, gene-therapeutic dosage control and metabolic biosensors constitute systems that otherwise require precise and robust signal transmission.^[@ref2]−[@ref9]^

A wide variety of natural input sensor types exist, which are overall represented by protein transcription factors^[@ref10],[@ref11]^ and RNA switches.^[@ref12],[@ref13]^ Despite an apparent abundance of candidate input sensors, only a modest number of such regulators are routinely used to build most synthetic circuits, namely protein-based input sensors such as LacI, LuxR and GAL4.^[@ref7],[@ref14]−[@ref18]^ RNA switches hold the potential advantage that their ligand-recognizing part, the aptamer, can be tailored synthetically for virtually any molecule using the SELEX technology.^[@ref19]^ Sophisticated sensor modules have been constructed on the basis of modular assembly of synthetic^[@ref20]^ and programmable *de novo* RNA switches.^[@ref21]^ Switches are limited in a number of aspects: input sensitivity, modularity and whether regulation is positive or negative, although recent progress in the design and understanding of RNA regulators has improved their scope of application.^[@ref14],[@ref22]−[@ref27]^

Specific adaptation of the regulatory properties of an RNA switch to fit the needs of a conceived genetic circuit can be made. For instance, change of sensitivity is possible through rational mutagenesis of the switch,^[@ref25]^ and riboswitch mutants with inverted outputs have been identified through elaborate screenings.^[@ref28]^ However, these adaptations are challenging and time-consuming.^[@ref29]^ In contrast, the response curve of transcription factor-based input sensors can be manipulated modularly, *e.g.*, by deploying synthetic signal drains and competitive inhibitors,^[@ref30],[@ref31]^ which render the signal ultrasensitive and can change the input trigger thresholds. Furthermore, modular signal inversion can be achieved based on translational fusions of the sensor to repressor/activator domains.^[@ref32],[@ref33]^

To minimize the need for tailoring riboswitch sensors to their specific conceived actuations, a modular signal-processing system offering control interfaces without need for changing the actual input and output parts is needed. In this study we set out to stabilize and transform ineffective responses of a tetracycline-responsive riboswitch by directing its output signals through a molecular signal buffer network to enable tunable population-wide selection. Such signal processing adds beneficial modular control points for switch-independent changes of input sensitivity and output direction. We therefore adapt the buffer concept to riboswitch regulation through the use of split transcription factors expressed at uneven ratios as buffer pairs.

Results {#sec2}
=======

Direct control of complex cellular actuations, such as cell survival by riboswitches can sometimes be challenging to achieve due to leaky expression although the same riboswitch with luminescent or fluorescent outputs yields quantitative and repeatable readouts. In spite of these challenges synthetic control of cell survival is required in order to enable library selections for specific phenotypes or to control cell populations in a variety of applications. To assess these challenges we engineered genetic constructs comprising a tetracycline-responsive riboswitch^[@ref34]^ that down-regulates translation of the classical yeast selection gene *URA3* in *Saccharomyces cerevisiae*. *URA3* mediates 5-fluoroorotic acid (FOA) sensitivity (FOA^S^), which permits negative selection. Despite a substantial down-regulation capacity of the riboswitch at 37-fold,^[@ref34]^ addition of tetracycline input resulted only in a limited improvement of growth with about 5-fold more colonies appearing on FOA^R^ spot assay selection plates ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}), similar to average 21 · 10^--4^ ± 4 · 10^--4^ colonies by plating, where 150 μM tetracycline supplementation increased the number to 103 · 10^--4^ colonies ± 17 · 10^--4^ (± standard error, *n* = 3).

![Colony formation in response to direct riboswitch-sensed input. Direct relay of the riboswitch signal to *URA3* caused poor control of colony formation (strain PRd5), further indicated by C-terminal GFP-tagging of URA3 (strain PRa116). The riboswitch (R) was expressed in the 5′-untranslated region of *URA3.* Colony formation responses were determined using spot assays with 10-fold serial dilution of equally dense cultures ([Methods](#sec4){ref-type="other"}) and representative examples of triplicate tests shown. GFP output was measured as background-subtracted relative fluorescence units (RFU) measured from a C-terminally GFP-tagged URA3 (PRa116), with error bars depicting standard error (*n* = 3). Plates were SC--leu--trp, with 0.09% (w/v) FOA in selective medium. 150 μM tetracycline was used as ligand in plates, 250 μM tetracycline in liquid cultures.](sb-2015-00213x_0001){#fig1}

In selections, cells that form colonies in the absence of the input are false positives. Due to single cell variation, these might, *e.g.*, form despite correct population-level *URA3* expression level. Equally undesirable are the false-negative cells that fail to form colonies despite receiving input. Both error types limit the possible throughput, *e.g.*, when assaying libraries. We wanted to ensure that *URA3* expression was within the dynamic range of cell death and survival. Too high basal *URA3* expression would mean that even the down-regulated *URA3* expression is too high to cause survival due to leakiness (false negatives). Oppositely, too low basal expression would constitutively cause survival (false positives). Since all plated cells did not form colonies with tetracycline ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}), the system appeared to yield false-negative cells. Similarly false-positive cells were indicated due to cells forming colonies in absence of tetracycline ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}).

This simultaneous occurrence of false-positive and false-negative cells indicated a fundamentally poor signal relay. We subsequently tagged the regulated URA3 C-terminally with GFP, which showed no tetracycline-dependent down-regulation, indicating incompatibility between URA3 and the riboswitch ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}). Such detrimental "part-junction" interference^[@ref35]^ might, *e.g.*, result from interacting mRNA structures, similar to interaction effects seen between promoters and circuit output, which could be buffered using ligand-independent ribozymes.^[@ref35]^ Thus, we speculated that an additional regulatory layer might provide important signal insulation, while further functioning as a signal-processing platform to modulate the riboswitch signals.

A Synthetic Molecular Signal Buffer to Effectively Relay the Riboswitch Signal {#sec2.1}
------------------------------------------------------------------------------

Biological and chemical systems maintain pH homeostasis by providing a surplus of interconvertible acid/base species. Their ratio influences pH and shows the capacity to react with fluctuating molecules to render them dysfunctional, rather than affecting pH, unless a specific threshold equivalence point is reached; *e.g.*, human blood is buffered stably to pH 7.4 Thus, we hypothesized that a simple, protein-based signal buffer can be engineered in a similar fashion.

One embodiment of such synthetic signal buffer would be a genetic network employing split transcription factors,^[@ref36]^ while this would simultaneously insulate the riboswitch. Here, the input-sensing riboswitch controls the translation of a hybrid activation domain (AD) from a transcription factor such as GAL4. At the same time, a separate, cognate GAL4 DNA-binding domain (DBD) is transcribed at equal levels to the AD transcript ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}). Thus, the DBD will be present in high numbers relative to the low number of DNA-binding sites positioned upstream of the output gene. The DBD thereby functions both as a mediator for the signal-correlated AD when bound to DNA, and as a surplus buffer molecule when DBD is not bound to DNA. Thus, the output would only be driven by the fraction of DBD~DNA~ bound to an AD molecule. Due to the buffering capacity of surplus DBD, this network architecture may also buffer against a few AD proteins unintentionally translated due to leakage or possible intermittent absence of riboswitch input in the riboswitch signals.

![Design of the molecular buffer network to modulate riboswitch signals. The signal-buffer design is composed of equal-level expression of the two independent GAL4 transcription factor domains, the riboswitch-regulated AD (blue) and the DBD (red), both fused to mutually interacting domains. The output gene of interest (GOI) is expressed from a minimal promoter featuring upstream binding sites for the DBD. When adding riboswitch ligand as input to the system, the translation of AD mRNA is inhibited, leading to a reduced expression of the GOI. The buffer system thus relays the riboswitch signal, while also insulating the output GOI.](sb-2015-00213x_0002){#fig2}

Mathematical Model of a Synthetic Signal Buffer System {#sec2.2}
------------------------------------------------------

We constructed a simple mathematical model for the conceived buffer network to guide the design. The model was built through application of ordinary differential equations (ODEs) describing the accumulation of mRNA and protein for the system ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}).

###### Ordinary Differential Equations Describing the Formation and Degradation of mRNA and Protein in the Split TF Buffer System, Given the Saturation Fractions *f* of Regulating Receptors (Riboswitch or TF)

  species                        differential equation
  ------------------------------ -----------------------
  AD mRNA                        
  DBD mRNA                       
  URA3 mRNA (driven by DBD:AD)   
  AD protein                     
  DBD protein                    
  GAL4 mRNA                      
  GAL4 protein                   
  URA3 mRNA (driven by GAL4)     
  URA3 protein                   

On the basis of equilibrium reactions between receptor R and ligand L, we derived simple Michaelis--Menten type saturation fractions (*f*) for receptor saturations given the formal L and R concentrations and their dissociation constant (*K*~d~) (more details in [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acssynbio.5b00213/suppl_file/sb5b00213_si_001.pdf)). Receptors and ligands notably represent several interactions in the network: riboswitch:tetracycline, DNA:DBD, DBD:AD.

The saturation fractions of these regulating receptors were subsequently used in the ODEs to linearly regulate the formation rates (*V*~form~) of cognate mRNA and protein (*i.e.*, the transcription and translation rates). Formation of a regulated species was further limited by a minimum and maximum value, describing a leakiness level, and a general reduction in translation strength, *e.g.*, as observed for riboswitches.^[@ref37]^

In the case of the buffer system, the general expression for *f* can both be used to model the fraction of DNA sites that is bound to DBD and the fraction of DBD that is bound to AD, assuming simple binding dynamics. Since we assume that the two interactions are independent of each other, we can multiply the two fractions to report the fraction of DNA sites that is bound by an AD-DBD complex, or the fraction of time that a given DNA site will be bound by an AD-DBD complex.

According to the model, the specific tuning of the buffer molecule levels significantly impacts function, and full utilization of the riboswitch regulation potential will be achieved with roughly equal expression of DBD and AD transcripts ([Figure S3](http://pubs.acs.org/doi/suppl/10.1021/acssynbio.5b00213/suppl_file/sb5b00213_si_001.pdf)).

Molecular Construction of the Synthetic Signal Buffer System {#sec2.3}
------------------------------------------------------------

To set up the buffer network in *S. cerevisiae*, cognate GAL4 AD and DBD proteins were expressed with equal strength from *ADH1* promoters with the tetracycline-responsive riboswitch down-regulating translation of AD ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}). Repeats of the cognate DNA-binding sites were positioned upstream of a minimal promoter from *SPO13.* This promoter features a natural UME6 repressor binding site to reduce system-independent expression, such as previously engineered for a yeast two-hybrid strain (SPAL10 in strain MaV203)^[@ref38]^ to allow GAL4-dependent regulation of *URA3* in a range affecting colony formation. After relaying the riboswitch signal through the buffer network, population-level control of the *URA3* phenotypes became possible in an *S. cerevisiae* strain deficient of wild type *GAL4* and *GAL80* ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}A). The signal-buffered strains acquired an ability to link colony formation to presence of the riboswitch input using classical FOA^R^ selection where false-positive cells were first observed when spotting 10^5^ cells ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}A) in the buffered strain. Further, since all plated cells formed colonies in the presence of tetracycline ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}A), both false-positive and false-negative colonies were reduced at the same time using the molecular buffer compared to the strain directly linking the signal from the riboswitch sensor to the output gene ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}). We also observed efficient tetracycline-dependent down-regulation of AD by C-terminal GFP tagging, confirming that the riboswitch signal was relayed when using the AD gene ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}A). Thus, insulated from the *URA3* gene, the riboswitch signal propagated correctly.

![Colony formation in response to riboswitch-sensed inputs using the engineered circuits. (A) Signal-buffered riboswitch relay provided full ligand-controlled colony formation (PRa22). (B) Relay of the riboswitch through the single-protein wild type transcription factor did not allow ligand-dependent colony formation (PRa28). (C) Modular inversion of the riboswitch signal by regulation *via* the GAL80 repressor (PRa84). The riboswitch (R) was expressed in the 5′-untranslated region of the illustrated target gene (AD, GAL4 or the GAL80 repressor). Colony-formation responses were determined using spot assays with 10-fold serial dilution of the cultures ([Methods](#sec4){ref-type="other"}) and representative examples of triplicate tests shown. GFP output was measured as background-subtracted relative fluorescence units (RFU) measured from a C-terminally GFP-tagged AD (PRa115), with error bars depicting standard error (*n* = 3). Plates were SC--leu--trp, with 0.09% (w/v) FOA in selective medium. 150 μM tetracycline was used as input ligand in plates, 150 μM tetracycline in liquid cultures.](sb-2015-00213x_0003){#fig3}

We hypothesized that the introduction of a buffering layer can provide additional, modular advantages for signal tuning unlike a possible insulation using a simple N-terminal tag. However, the complete network also must be carefully balanced and thus we first tested the importance of the introduced DBD buffer molecules compared to simply passing the signal through a transcription factor layer employed at the same transcriptional strength but without buffering. Likely due to the high expression level and concomitant constitutive DNA saturation, use of a single-protein, wild type GAL4 transcription factor resulted in no control of colony formation ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}B) despite possessing the same DNA-binding domain (as modeled [Figure S4](http://pubs.acs.org/doi/suppl/10.1021/acssynbio.5b00213/suppl_file/sb5b00213_si_001.pdf)). As indicated in a riboswitch selection study, such direct riboswitch control of a full transcription factor likely requires use of a much weaker expression level (driven by *CYC1* promoter).^[@ref39]^

Modular Inversion of Sensor Signals {#sec2.4}
-----------------------------------

The need for ON or OFF switches in genetic circuits depends on the desired actuations and outputs. To allow the combination of OFF riboswitches with gain-of-function genes, we wanted to demonstrate the ease by which riboswitch signals can be treated modularly with the synthetic buffer network and a repressor module. Engineering of regulated repression by adding repressor-binding sites within synthetic/hybrid promoters can be challenging. Instead we took advantage of the constructed, robust activation modules and inverted the signal modularly by relaying the OFF signal to the GAL80 antiactivating repressor, which binds and inhibits GAL4 AD.^[@ref40]^ In this way signal inversion results from expressing the genes encoding DBD and AD with the same transcriptional strength as a gene encoding GAL80 controlled by the tetracycline riboswitch. With these strains using the exact same sensor and output modules, the opposite colony formation behavior was observed ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}C) compared to the first buffered strain, although the frequency of false positives increased by 10-fold, indicating that the expression level of GAL80 could be further optimized relative to DBD and AD.

Using the Synthetic Buffer Network for Modular Tuning of Input Sensitivity {#sec2.5}
--------------------------------------------------------------------------

The sensitivity of a riboswitch for its ligand depends on molecular RNA interactions, which are nontrivial to engineer.^[@ref25]^ Instead, our model suggested that the sensitivity could be modularly shifted by perturbing the transcriptional ratios of AD to DBD (AD~0~:DBD) while maintaining the riboswitch unchanged ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}A). We calculated steady state concentrations of URA3 at different tetracycline concentrations and transcriptional AD~0~:DBD ratios by setting the ODEs equal to zero. The AD~0~:DBD ratio was varied by changing the DBD transcription rate while keeping AD transcription rate constant.

![Tuning the effective sensitivity for the ligand by modulating the transcriptional ratio of AD and DBD in the buffered network with fluorescence and colony formation as output. (A) Model showing the effect on output (*URA3* expression) by changing the AD:DBD transcriptional ratio (AD~0~:DBD) or adding riboswitch ligand. (B) Dynamic range tuning measured in *S. cerevisiae* with 6xGFP as output. Background-subtracted relative fluorescence units (RFU) are shown responding to added riboswitch ligand (tetracycline) for two strains AD~1~ and AD~2~ with perturbed AD~0~:DBD, error bars denote std. error (*n* = 3). The output is shown with the fit to the model with linear *x*-axis and in the small window with logarithmic *x*-axis. (C) Shifted trigger point for colony formation of the two perturbed strains spotted in 10-fold serial-dilution spot assays of equally dense cultures on SC--leu--trp +0.09% FOA with indicated riboswitch ligand concentrations (tetracycline) (one representative experiment shown from triplicates).](sb-2015-00213x_0004){#fig4}

By introducing more free AD molecules relative to DBD in the system, a higher number of input molecules (*i.e.*, larger AD reduction) would be required to lead to the same output. Thus, an increased ligand concentration would be required in order to produce an AD:DBD protein ratio that outputs a survival response ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}A).

To test this experimentally, we perturbed the ratios by introducing the weaker *CUP1* promoter to drive DBD expression as a low-expression alternative to the *ADH1* promoter^[@ref41]^ otherwise used. The response curves of the two perturbed systems measured with 2 × 3 tandem green fluorescent protein (2× 3vGFP)^[@ref42]^ displayed this response shift and the changed curvature was fitted to our model ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}B) with high confidence (*R*^2^ = 0.98 and 0.96). The increase of AD:DBD transcriptional ratio resulted in a vertical response increase, probably due to a higher degree of AD-binding to DNA-bound DBD. More interestingly and as predicted, it also introduced a horizontal right-shift, thus increasing the number of ligand molecules needed to produce the same absolute expression level and produce the same relative down-regulation from the maximum. This horizontal shift could also be relayed to colony-formation output ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}C). The increased AD:DBD transcription ratio effectively shifted the ligand sensitivity threshold to trigger survival at an increased ligand concentration. Whereas the strain AD~1~ with *ADH1*-based expression of AD and DBD required 50 μM tetracycline to trigger the survival, the strain AD~2~ with increased AD:DBD transcription ratio required 150 μM tetracycline to trigger survival ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}C). As predicted by the model, the low threshold concentration could be reconstituted by simply reducing the absolute transcription levels for AD as much as for DBD, hence reestablishing the 1:1 transcriptional AD:DBD ratio ([Figure S5](http://pubs.acs.org/doi/suppl/10.1021/acssynbio.5b00213/suppl_file/sb5b00213_si_001.pdf)). Much like pH buffers, the output did not change notably in response to absolute changes in the concentration of the interacting buffer pairs when their mutual ratio was kept the same.

Discussion {#sec3}
==========

In next-generation synthetic systems, biological signal interfaces that improve parts' interoperability are needed to meet the challenge of designing diverse biological functions using diverse biological parts. Recently, such progress has been attained using spatial insulators to limit the negative impact from the genetic context of the combined parts^[@ref35]^ or using modular signal transduction scaffolds with autoinhibition.^[@ref43]^ In other systems, better I/O coherence has been obtained through use of directed evolution approaches or extensive tuning libraries sampling the functional circuit space.^[@ref15],[@ref44]^ Another powerful method for signal improvement is the use of protein sequestration to generate ultrasensitivity and to transform graded signals into binary forms.^[@ref30],[@ref45]^ Ultrasensitivity can result if the buffering molecules have higher affinity for the input signal than the output relay has,^[@ref46]^ whereas in our demonstration, the buffering agent is the same protein as the output relay. Molecular buffering may be a natural signal stabilization strategy. In fact, buffering of noise in some natural systems has been predicted as a result of the order of dimer transcription factor binding, which produces a pool of signal stabilizing, inactive monomers.^[@ref47]^ In this study, we demonstrated that design principles of molecular buffers can be reconstructed synthetically to effectively tune and utilize the signal response of a riboswitch, allowing new cellular actuations, while also insulating the riboswitch from the nucleotide context. Adapted from pH-stabilizing buffers, this protein-based buffer device allowed the modular tuning of riboswitch signals. Similarly, the input trigger threshold for shifting the output phenotype could be tuned by changing the ratio of the buffer proteins, analogous to how pH buffer ratios affect the stabilized pH.

Signal modulation has been described employing different pools of "unfunctional" response mediators such as antiactivators and shunt DNA-binding sites to change GFP-based outputs.^[@ref30],[@ref48],[@ref49]^ Introducing signal computation based on protein--protein interactions, this concept alleviates issues with tuning the expression level of DNA-binding proteins such as repressors at levels of a few molecules per cell where unintended, constitutive oversaturation of the binding sites will result in loss of signal. Using split transcription factors, we instead rely on customized protein--protein interaction of hybrid proteins. Lower binding affinity between these parts allows responses to transmit at higher signal molecule concentrations, which may provide stability toward fluctuations. These provide an easy protein--protein interaction control point for inversion of the signal direction, which is often important as many output genes work only with ON signals.

These different generic interaction interfaces of the network may serve to further incorporate multicomponent signal schemes comprising, *e.g.*, sub-buffer systems by engineering specific conditional DBDs and specific protein-interaction domains without module cross talk. We also anticipate that the signal-stabilizing network engineered in this study could be reconstructed in quite different synthetic embodiments by implementation of other buffer molecules cognate to an otherwise fluctuating signal. By taking advantage of the natural concept of molecular signal buffers, these systems will aid the large-scale domestication of wild type or synthetic input sensors for more predictable, customized cell reprogramming.

Methods {#sec4}
=======

Standard methods for strain construction and molecular biology in *S. cerevisiae* and *Escherichia coli* were used. All plasmids and chromosomal deletion substrates cloned in this study were constructed using uracil-excision cloning^[@ref50]^ by assembly of PCR fragments as described in [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acssynbio.5b00213/suppl_file/sb5b00213_si_001.pdf). Complete cloning and strain construction methods, strain lists and plasmid lists are given in [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acssynbio.5b00213/suppl_file/sb5b00213_si_001.pdf).

Colony Formation Response Assays {#sec4.1}
--------------------------------

Four mL synthetic complete (SC) medium (2% glucose, pH = 5.6) lacking leucine (leu) and tryptophan (trp) was inoculated with a single colony of the strain and split into two halves for preculturing with/without the riboswitch ligand (150 μM tetracycline) for 18 h at 30 °C, 175 rpm horizontal shaking. Each culture was 10-fold serial diluted in a 96-well plate, such that each dilution contained 100 μL of volume. Five μL of each dilution (both precultures) was spotted onto SC--leu--trp plates (pH = 4.5) and the respective assay plates, supplemented with 0.09% (w/v) FOA and the relevant concentration of tetracycline. Preparation of FOA-containing plates is further described in [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acssynbio.5b00213/suppl_file/sb5b00213_si_001.pdf). Plates were incubated in darkness at 30 °C for 3 days. For spot assays, equal cell concentrations between strains and conditions were controlled by evaluation of the spots on SC -leu -trp plates. Photographs were taken with a ColonyDoc-It (UVP).

GFP Response Assays {#sec4.2}
-------------------

Precultures of the strains PRa74 (background), PRa78 (AD~1~) and PRa79 (AD~2~) were inoculated from a single colony of the strain in SC medium (2% glucose, pH = 5.6) lacking leu, trp and histidine. Following 18 h of cultivation at 30 °C, 175 rpm horizontal shaking, 200 μL microtiter main cultures were inoculated from these in 75% SC medium (diluted with Milli-Q water and back-standardized to 2% glucose) with the relevant concentrations of tetracycline added. The cultures were sealed with a gas-permeable Breathseal (Greiner bio-one) and plastic lid and were cultured in a horizontal shaker (Innova) at 30 °C, 300 rpm shaking. Following 16 h of cultivation, the cultures were measured by flow cytometry on a BD LSRFortessa Cell Analyzer using a FITC filter with collection limit set to 10 000 cells. The mean FITC intensity for each sample was reported. The measurements from the GFP-devoid PRa74 strain were used for background-subtraction.

Direct Riboswitch Response (GFP-Tagging) {#sec4.3}
----------------------------------------

Precultures of the strains PRa18 (background), PRa115 (AD-GFP) and PRa116 (URA3-GFP) were inoculated from a single colony of the strain in SC medium (2% glucose, pH = 5.6) lacking the relevant auxotrophic selection dropout (leu or trp). Following 18 h of cultivation at 30 °C, 250 rpm horizontal shaking, 4 mL cultures of SC medium (2% glucose, pH = 5.6, 250 μM Cu^2+^) were inoculated from the precultures (by 100× back-dilution) and with the relevant concentrations of tetracycline added. Following 16 h of cultivation at 30 °C, 250 rpm horizontal shaking, the cultures were measured in a Synergy H1 reader (BioTek) with 485 nm excitation, 528 nm emission and standardized to the cell density (OD600). The measurements from the GFP-devoid PRa18 strain were used for background-subtraction.

The Supporting Information is available free of charge on the [ACS Publications website](http://pubs.acs.org) at DOI: [10.1021/acssynbio.5b00213](http://pubs.acs.org/doi/abs/10.1021/acssynbio.5b00213).Detailed description of mathematical model; No regulation of output when controlling expression of GAL4; Re-establishing AD:DBD transcription ratio re-establishes response; Detailed methods and materials; Model (Python) script. ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acssynbio.5b00213/suppl_file/sb5b00213_si_001.pdf))
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